Topics

Vertex Pharmaceuticals (Europe) Limited Company Profile

02:57 EDT 26th August 2019 | BioPortfolio

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat the underlying cause of cystic fibrosis – a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational medicines in other serious diseases where it has deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney disease.


News Articles [1598 Associated News Articles listed on BioPortfolio]

Vertex Pharmaceuticals Exec Ian Smith Fired for “Personal Behavior”

Ian Smith, chief operating officer and interim chief financial officer of Vertex Pharmaceuticals, has been terminated from his positions following an investigation, the company announced Wednesday. Bo...

Vertex Pharmaceuticals to buy US firm Exonics Therapeutics

Under the deal, Exonics equity holders will receive $245m (£192m) upfront payment from Vertex, as well as potential future payments based on the achievement of specified development and The post Ver...

Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its second quarter that increased from last year.The company's profit came in at $267 million, or $1....

Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) announced a profit for its fourth quarter that climbed from the same period last year.The company's earnings came in at $1....

Vertex Continues Plan to Diversify, Strikes a $70M Pact With Kymera

Vertex Pharmaceuticals is best known for its cystic fibrosis franchise. But over the past several years Vertex has been making inroads elsewhere, and a deal it is announcing this morning continues tha...

Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) revealed earnings for its first quarter that advanced from the same period last year.The company's earnings totaled $269 mi...

Vertex Pharmaceuticals Taps Ortho Clinical’s Wagner for CFO Post

Two months after Vertex Pharmaceuticals (NASDAQ: VRTX) terminated its top financial executive for “personal behavior,” the Boston company has named a permanent replacement. Vertex, a developer of ...

Vertex Pharmaceuticals erweitert Zusammenarbeit mit CRISPR

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Michel Doepke, Redakteur des Online-Anlegermagazins "Der Aktionär": Michel Doepke von "Der Aktionär" nimmt in einer aktuelle....

Drugs and Medications [44 Associated Drugs and Medications listed on BioPortfolio]

Adenosine [wockhardt limited]

Adenosine Injection, USP FOR RAPID BOLUS INTRAVENOUS USE

Felodipine [wockhardt limited]

Felodipine Extended-Release Tablets, USP Rx only

Ranitidine [wockhardt limited]

Ranitidine Syrup (Ranitidine Oral Solution, USP)

Risperidone [wockhardt limited]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Amlodipine besylate [wockhardt limited]

These highlights do not include all the information needed to use amlodipine besylate tablets safely and effectively. See full prescribing information for amlodipine besylate tablets. Amlodipine Besyl...

PubMed Articles [548 Associated PubMed Articles listed on BioPortfolio]

Vertex corrections to the polarizability do not improve the GW approximation for ionization potentials of molecules.

The GW approximation is based on the neglect of vertex corrections, which appear in the exact self-energy and the exact polarizability. Here, we investigate the importance of vertex corrections in the...

Localization of eigenvector centrality in networks with a cut vertex.

We show that eigenvector centrality exhibits localization phenomena on networks that can be easily partitioned by the removal of a vertex cut set, the most extreme example being networks with a cut ve...

Occurrence and distribution of pharmaceuticals in raw, finished, and drinking water from seven large river basins in China.

The occurrence of pharmaceuticals in the drinking water is a growing concern in China. In this study, we determined the concentration and distribution of 59 selected pharmaceuticals in raw, finished, ...

Insight into the distribution of pharmaceuticals in soil-water-plant systems.

Pharmaceuticals in agricultural soils originating from irrigation with treated wastewater and land-applied biosolids can enter field crops. However, little is known about the role of pore water in pla...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Clinical Trials [954 Associated Clinical Trials listed on BioPortfolio]

Early Versus Delayed Pushing in the Second Stage of Labor

Nulliparous women in spontaneous or induced labour with term singleton pregnancy are randomized into two groups first group (early pushing) in this group patients were allowed to push with...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [2342 Associated Companies listed on BioPortfolio]

Vertex Pharmaceuticals Inc.

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989, Vertex toda...

Vertex Pharmaceuticals (Europe) Limited

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat...

Vertex Pharmaceuticals Incorporated

Second Quarter and Six Month Results

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Lupin Pharmaceuticals Inc.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, and is the 4th largest pharmaceutical company in the U.S. based on prescriptions filled. To...

More Information about "Vertex Pharmaceuticals (Europe) Limited" on BioPortfolio

We have published hundreds of Vertex Pharmaceuticals (Europe) Limited news stories on BioPortfolio along with dozens of Vertex Pharmaceuticals (Europe) Limited Clinical Trials and PubMed Articles about Vertex Pharmaceuticals (Europe) Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vertex Pharmaceuticals (Europe) Limited Companies in our database. You can also find out about relevant Vertex Pharmaceuticals (Europe) Limited Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record